一、监事会会议召开情况 北京格灵深瞳信息技术股份有限公司（以下简称"公司"）第二届监事会第 十四次会议（以下简称"本次会议"）于2025年9月10日在公司会议室召开。本 次会议通知已提前以邮件方式发送。本次会议由监事会主席王雨濛先生主持，应 出席监事3名，实际出席监事3名。会议的召集和召开程序符合有关法律、行政法 规、部门规章、规范性文件和公司章程的规定，会议决议合法、有效。 证券代码：688207 证券简称：格灵深瞳 公告编号：2025-056 北京格灵深瞳信息技术股份有限公司 第二届监事会第十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 二、监事会会议审议情况 出席会议的监事对各项议案进行了认真审议并做出了如下决议： （一）审议通过《关于取消监事会暨修订<公司章程>的议案》 监事会认为，根据《中华人民共和国公司法》（以下简称"《公司法》"） 《上市公司章程指引》《上海证券交易所科创板股票上市规则》等法律、法规和 规范性文件的相关规定，结合公司实际情况，同意取消监事会，由审计委员会行 使《公司法》规定 ...

格隆汇9月10日丨格灵深瞳(688207.SH)公布，公司拟使用1.8亿元超募资金及1,274.98万元（实际金额以 资金转出当日募集资金专户余额为准）节余募集资金永久补充流动资金，其中拟使用的超募资金占超募 资金总额的比例为26.86%。 ...

Core Viewpoint - The company announced that its controlling shareholder and related entities have committed not to reduce their holdings of company shares for a specific period, reflecting confidence in the company's future development and long-term investment value [1][5][21]. Group 1: Shareholder Commitment - The controlling shareholder, Tianjin Deep Vision Intelligent Technology Center (Limited Partnership), and related entities have pledged not to transfer or reduce their directly held shares for six months starting from September 17, 2025 [1][5][21]. - This commitment applies to any shares generated from capital reserves, stock dividends, rights issues, or new share issuances during the commitment period [1][5]. Group 2: Shareholding Situation - As of the announcement date, the shareholders making the non-reduction commitment directly hold a total of 70,296,841 shares, which represents 27.14% of the company's total share capital [6][18]. - The actual controller of the company, Zhao Yong, is the actual controller of Tianjin Deep Vision Intelligent Technology Center (Limited Partnership) and serves as the executive partner for the related entities [2][19]. Group 3: Listing of Restricted Shares - The company is set to list 70,296,841 restricted shares for circulation on September 17, 2025, following the expiration of the lock-up period [5][6][20]. - The total share capital of the company after the initial public offering (IPO) was 184,980,819 shares, with 142,434,121 shares being restricted [6][7]. Group 4: Compliance and Oversight - The company's board of directors will continuously supervise the fulfillment of the above commitments and will timely perform information disclosure obligations [3][16]. - The underwriting institution has confirmed that the shareholders have strictly adhered to their respective commitments regarding share lock-up [16][17].

Group 1 - The company, Geling Deep Vision, announced the listing of its shares as a first-time restricted stock offering [1] - The total number of shares being listed is 70,296,841 [1] - The shares will be available for trading starting from September 17, 2025 [1]

Group 1 - Matrix Co., Ltd. announced that its wholly-owned subsidiary, Anke Technology, introduced a strategic investor, Shenzhen Jifu New Industry Venture Capital Fund, which invested 5 million yuan for a 10% stake [1] - Heng Rui Medicine received approval from the National Medical Products Administration for its Eicosapentaenoic Acid Ethyl Ester Soft Capsule, aimed at reducing triglyceride levels in patients with severe hypertriglyceridemia [1] - Mo Gao Co., Ltd. announced the resignation of its Vice President Jin Baoshan due to job transfer [1] Group 2 - Yao Wang Technology decided to terminate two fundraising projects and will permanently supplement the remaining funds into working capital [2] - Minhe Livestock reported sales of 25.53 million chicklings in August, generating revenue of 86.41 million yuan, with year-on-year growth of 27.60% [2] - Sichuan Jinding announced the resignation of its Director and General Manager Xiong Jifeng due to personal reasons [3] Group 3 - Taiji Group received approval for clinical trials of its Semaglutide Injection, aimed at blood sugar control in type 2 diabetes patients [5] - Jieput announced plans to increase capital in its affiliate, Suidong Intelligent Technology, with an investment of 5 million yuan for a 5% stake [7] - GeLing Deep Vision's controlling shareholders committed not to reduce their shareholdings for six months starting from September 17, 2025 [8] Group 4 - Huafeng Superfiber reported the resignation of its Vice President Liu Cong due to personal reasons [9] - Xiaoming Co., Ltd. reported sales revenue of 79.90 million yuan from chicken products in August, with year-on-year growth of 11.73% [11] - Lion Head Co., Ltd. announced that its application for issuing shares and cash to acquire assets has been accepted by the Shanghai Stock Exchange [12] Group 5 - Jinlong Automobile reported a bus sales volume of 4,074 units in August, a year-on-year increase of 23.6% [43] - Metro Design signed a contract for the Ho Chi Minh City urban rail transit project in Vietnam, with a total amount of 1.754 trillion VND [45] - North New Road and Bridge announced winning a mining construction project worth 504 million yuan [28]

Group 1 - The core point of the article is that the controlling shareholder of Geling Deep Vision (688207.SH) has committed to not reducing its shareholding in the company for a specific period, reflecting confidence in the company's future development and long-term investment value [1] Group 2 - The controlling shareholder, Tianjin Deep Vision Intelligent Technology Center (Limited Partnership), along with related entities, has pledged not to transfer or reduce their directly held shares for six months starting from September 17, 2025 [1] - The commitment also applies to any shares generated from capital reserve conversion, stock dividends, rights issues, or additional issuances during the commitment period [1]

证券代码：688207 证券简称：格灵深瞳 公告编号：2025-054 北京格灵深瞳信息技术股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 70,296,841股。 本次股票上市流通总数为70,296,841股。 本次股票上市流通日期为2025 年 9 月 17 日。 根据中国证券监督管理委员会于 2022 年 1 月 11 日出具的《关于同意北京格 灵深瞳信息技术股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕 64 号），同意公司首次公开发行股票的注册申请。公司首次向社会公众公开发行 人民币普通股（A 股）股票 46,245,205 股，并于 2022 年 3 月 17 日在上海证券交 易所科创板上市，发行完成后总股本为 184,980,819 股，其中有限售条件流通股 142,434,121 股，占公司股本总数的 77.00%，无限售条件流通股 42,546,698 股，占 ...

国泰海通证券股份有限公司 关于北京格灵深瞳信息技术股份有限公司 首次公开发行部分限售股上市流通的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 北京格灵深瞳信息技术股份有限公司（以下简称"格灵深瞳"或"公司"）首次 公开发行股票并在科创板上市及持续督导的保荐机构，根据《证券发行上市保荐 业务管理办法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创 板上市公司自律监管指引第 1 号——规范运作》等法律法规的相关规定，对格灵 深瞳首次公开发行部分限售股上市流通事项进行了核查，核查情况及核查意见如 下： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2022 年 1 月 11 日出具的《关于同意北京格 灵深瞳信息技术股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕 64 号），同意公司首次公开发行股票的注册申请。公司首次向社会公众公开发行 人民币普通股（A 股）股票 46,245,205 股，并于 2022 年 3 月 17 日在上海证券交 易所科创板上市，发行完成后总股本为 184,980,819 股，其中有限售条件流通股 142,434,121 ...

北京格灵深瞳信息技术股份有限公司 关于控股股东及相关主体承诺特定期间不减持公司 股份的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 北京格灵深瞳信息技术股份有限公司（以下简称"公司"）近日分别收到公 司控股股东天津深瞳智数科技中心（有限合伙）及相关主体天津灵瞳众智科技中 心（有限合伙）、天津灵瞳莱客科技中心（有限合伙）、天津灵瞳智源科技中心 （有限合伙）及天津灵瞳数源科技中心（有限合伙）的《关于特定期间不减持公 司股份的承诺函》，相关情况具体如下： 一、承诺函主要内容 证券代码：688207 证券简称：格灵深瞳 公告编号：2025-055 | 序号 | 股东名称 | 持有股份数 | 持有股份占公司 | | --- | --- | --- | --- | | | | 量（股） | 总股本比例 | | 1 | 天津深瞳智数科技中心（有限合伙） | 43,765,884 | 16.90% | | 2 | 天津灵瞳众智科技中心（有限合伙） | 13,331,285 | 5.15% | | --- | --- | ...

格隆汇9月9日丨格灵深瞳(688207.SH)公布，近日分别收到公司控股股东天津深瞳智数科技中心（有限 合伙）及相关主体天津灵瞳众智科技中心（有限合伙）、天津灵瞳莱客科技中心（有限合伙）、天津灵 瞳智源科技中心（有限合伙）及天津灵瞳数源科技中心（有限合伙）的《关于特定期间不减持公司股份 的承诺函》，基于对公司未来发展前景的信心及长期投资价值的认可，公司控股股东天津深瞳智数科技 中心（有限合伙）及相关主体天津灵瞳众智科技中心（有限合伙）、天津灵瞳莱客科技中心（有限合 伙）、天津灵瞳智源科技中心（有限合伙）、天津灵瞳数源科技中心（有限合伙）均承诺自2025年9月 17日起未来6个月内不以任何方式转让或减持其直接持有的公司股份；承诺期内如发生资本公积转增股 本、派送股票红利、配股、增发等产生的股份，亦遵守上述承诺。 ...